Sanofi SA header image

Sanofi SA

SNY

Equity

ISIN null / Valor 1447201

NASDAQ (2026-08-06)
USD 42.89+0.26%

Sanofi SA
UMushroom community rating:

star star star star star
4.00 2 votes No rating yet
NegativeNeutralPositive

About company

Sanofi SA is a Paris-headquartered, publicly traded multinational pharmaceutical company that researches, develops, manufactures and commercializes prescription medicines, vaccines and consumer health products for global markets. Its business spans vaccines (Sanofi Pasteur) and a pharmaceuticals portfolio focused on areas such as immunology, rare diseases, oncology, diabetes and cardiovascular care, with a mix of small-molecule and biologic medicines; the company also markets over‑the‑counter and consumer healthcare products. Sanofi generates revenue from product sales and partnerships with other biopharma firms, supports an active R&D pipeline across therapeutic areas, and operates global manufacturing and distribution networks to supply markets worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-7.12%1Y
-17.0%3Y
-15.7%5Y

Performance

26.8%1Y
62.1%3Y
50.3%5Y

Volatility

Market cap

102770 M

Market cap (USD)

Daily traded volume (Shares)

4,147,027

Daily traded volume (Shares)

1 day high/low

48.65 / 48.21

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

2 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
3.50
Society:
starstarstarstarstar
3.50
Nature:
starstarstarstarstar
3.50
Milena Klasing Chen
Switzerland, 30 Mar 2025
star star star star star
Stable
Milena Klasing Chen
Switzerland, 24 Mar 2025
star star star star star
Ok

EQUITIES OF THE SAME SECTOR

BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.99%USD 82.80
Alkem Laboratories Ltd.
Alkem Laboratories Ltd. Alkem Laboratories Ltd. Valor: 30689895
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%INR 5,608.45
Insmed Inc
Insmed Inc Insmed Inc Valor: 12614415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
33.86%USD 132.55
Laurus Labs Ltd.
Laurus Labs Ltd. Laurus Labs Ltd. Valor: 56464789
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%INR 1,836.00
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.27%INR 834.60
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Ltd. Narayana Hrudayalaya Ltd. Valor: 30795490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.98%INR 1,883.80
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.76%INR 562.55
Cohance Lifesciences Ltd
Cohance Lifesciences Ltd Cohance Lifesciences Ltd Valor: 46346459
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.54%INR 439.85
Gland Pharma Ltd.
Gland Pharma Ltd. Gland Pharma Ltd. Valor: 56038514
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.82%INR 2,617.50
MEDICLIN AG
MEDICLIN AG MEDICLIN AG Valor: 1158721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.31%EUR 4.22